Article
The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation.
The Journal of endocrinology - 1 Feb 2006
Sentinelli F, Filippi E, Cavallo M G, Romeo S, Fanelli M, Baroni M G
Abstract excerpt
The insulin receptor substrate-1 (IRS-1) plays a central role in insulin sensitivity, and association studies have shown that the IRS-1 G972R variant is a risk factor for insulin resistance. However, how this mutation may lead to impaired insulin sensitivity is still to be determined. Our study aimed to evaluate, after transfection of the IRS-1 G972R variant in 3T3L1 adipocytes, the effect of this mutation on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
